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Abstract
Mitochondria play a significant role in human diseases. However, disease associations with
mitochondrial DNA (mtDNA) SNPs have proven difficult to replicate. An analysis of eight
schizophrenia-associated mtDNA SNPs, in 23,743 Danes without a psychiatric diagnosis
and 2,538 schizophrenia patients, revealed marked inter-allelic differences in mitochondrial
haplogroup affiliation and nuclear ancestry. This bi-genomic dependence could entail popu-
lation stratification. Only two mitochondrial SNPs, m.15043A and m.15218G, were signifi-
cantly associated with schizophrenia. However, these associations disappeared when
corrected for haplogroup affiliation and nuclear ancestry. The extensive bi-genomic depen-
dence documented here is a major concern when interpreting historic, as well as designing
future, mtDNA association studies.
Introduction
Genetic variants in mitochondrial DNA (mtDNA)—and in nuclear genes coding for mito-
chondrial function—have been associated with disease [1–3]. More than 300 variants [4, 5] in
mtDNA and genes involved in mitochondrial function [6] have been reported to cause mito-
chondrial disease, which is clinically characterized by complex metabolic, neurological, mus-
cular and psychiatric symptoms [7, 8]. SNPs in mtDNA and mitochondrial haplogroups
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(mtDNA hgs), which are evolutionarily fixed SNP sets with a characteristic geographical
distribution, have been proposed as potential disease modifiers[8]. This has been reported in
neurological degenerative diseases such as Alzheimer’s disease [9–12] and Parkinson’s disease
[12–14], metabolic diseases and cancers [15], as well as psychiatric diseases, notably schizo-
phrenia (SZ) and bipolar disease [16–18].
Association studies of mtDNA variants and disease have been difficult to replicate[8]. How-
ever, the definition of a methodological paradigm for association studies with mtDNA variants
[19] implicitly assumes that mtDNA variants are independent of the nuclear genome (gDNA).
In a recent Danish study on mtDNA hgs and their nuclear ancestry, we demonstrated a
marked difference in nuclear ancestry between individual mtDNA hgs [20]. This means that
mtDNA hgs entail population stratification also at the level of gDNA. The effect of such a strat-
ification on disease association will depend on the admixture structure of the particular popu-
lation, the population history, epidemiology and genetic epidemiology of the disease, as well as
the number of persons included in the study. The extensive fine-scale heterogeneity of gDNA
and significant admixture documented in the UK [21] and Europe [22] further increase the
risk of spurious false positive associations, if the mtDNA/gDNA interaction is not corrected in
association studies.
Using DNA-array data from the Danish iPSYCH study on 2,538 SZ patients and 23,743
population controls, we show that eight mtDNA SNPs, previously associated with SZ [16–18,
23], exhibit considerable inter-allelic differences both with respect to mtDNA hg affiliation
and nuclear ancestry. This phenomenon, which we name bi-genomic dependence, affects the
association between an mtDNA SNP and mtDNA, as well as gDNA, and can lead to both false
negative and positive associations with disease. We demonstrate that, in this cohort, it is only
possible to replicate the association results for two of the original eight SNPs, when correcting
for population stratification. Both mtDNA hg affiliation and nuclear ancestry affects the
strength of association. Finally, we show that none of the SNPs are associated with SZ when
examined on a particular mtDNA hg background, with correction for bi-genomic dependence.
As none of previous studies of mtDNA SNPs have been performed with correction for popula-
tion stratification, let alone bi-genomic dependence, our results indicate that all such published
associations should be considered preliminary. In principle, this conclusion should not be lim-
ited to associations with SZ.
Results
From a literature search of mtDNA SNPs previously associated with SZ, we identified eight
that were also typed by the PsychChip, Table 1. PsychChip data from 23,743 normal Danes
and 2,538 SZ patients (Detailed in S1 Table) showed that the SNPs were present in the popula-
tion with frequencies varying from 0.2%– 20.6%, Table 1. There was no appreciable difference
in mtDNA hg or nuclear ancestry distribution between controls and SZ patients, S1 and
S2 Figs.
Haplogroup distribution of mtDNA SNPs
The potential affiliation, based on PhyloTree, of SNPs to different mtDNA hgs is shown in
Table 1, and the actual mtDNA hg distribution in the controls (not different from that of the
SZ patients, S1 Fig) is shown in Fig 1. For all SNPs, there is a marked difference in the actual
mtDNA hg distribution between the two alleles at the same position. Thus, when comparing
persons with either of two alleles at the same mtDNA position, the comparison is between
groups with widely differing mtDNA distributions. A PCA analysis of the mtDNA sequences
in persons with either the A or G allele at position 15,043 is shown in Fig 2A. This analysis
Bi-genomic dependence obscures schizophrenia-association with mtDNA SNPs
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shows that the difference in mtDNA sequence, while subtle, indicates independent mtDNA
distribution between the alleles.
Nuclear ancestry of mtDNA SNPs
The distribution of nuclear ancestries in control persons as a function of each mtDNA allele
revealed major differences, both between different positions (inter-SNP) in the mtDNA
Table 1. Schizophrenia associated mtDNA SNPs, their frequency, mtDNA hg association, and link with disease.
Variant Locus Molecular
effect
Effect on risk
of SZ
% DK iPSYCH
controls (SZ)
Theoretical mtDNA hg associations�
m.1438A [17] MT-RNR1 n.a. SZ" 4.6 (4.8) L0d, L1, C1b4, C4c2, M32056, D5a2, I5c1, H1b1g, H2, H13a2b5, H14a2c, J1b1b1c, P2, P5
m.3197C [18] MT-RNR2 n.a. SZ" 7.3 (8.2) U5a0b, L3f1a1, H14b, U2e1a1a
m.3666A [16] MT-ND1 p.G120G SZ" 0.3 (0.4) L0d1c1a1a, L0d1b2b2c2, L1, M13c, H1ak, R9b2, F1a1c, U5a2b3a1
m.4769A [17] MT-ND2 p.M100M SZ" 4.4 (4.6) R2, B4a1a1c, B4a1a4, L0d2b1, H2a
m.9377G [16] MT-CO3 p.W57W SZ# 0.5 (0.6) G2a, Q2a1, D5b2, A2ac, H1c9a, U6a1b4, K1a4a1a2a, L2e, L3e2b1
m.10398G
[23]
MT-ND3 p.T114A SZ" 20.6 (19.1) K1, J, R11, B4m, B4c1c, R12021, P4, U6a5c, K2a11, U8c, N1a1, W1e1a, W3a1d, N8, Y, S3,
X2f1, R0a2k1, B5
m.15043A
[18]
MT-CYB p.G99G SZ" 5.7 (4.6) M, N1a1, L2c2a, J1c2a3, T2f1a, U6a7, U2c1a
m.15218G
[18]
MT-CYB p.T158A SZ" 4.3 (5.2) U5a1, M7a1a2, M10a1, HV1a0b0c, H13a2c
�Based on PhyloTree.
https://doi.org/10.1371/journal.pone.0208828.t001
Fig 1. The percentage distribution of mtDNA hgs, per allele, among control individuals.
https://doi.org/10.1371/journal.pone.0208828.g001
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molecule and between different alleles (inter-allelic) at the same position, Fig 3. Apart
from subtle differences in the distributions of Greenlandic and Asian ancestral affiliations, the
distribution is similar in SZ patients, S2 Fig. The nuclear ancestry was statistically different
between the alleles of seven of the eight SNPs assessed by chi-squared test; m.1438, m.3197,
m.4769, m.10398 and m.15043 were statistically highly significant (P-value = 2.6e-7, 1.34e-6,
2.45e-7, 2.2e-162.2e-16 respectively) and m.3666 and m15218 were statistically significant
(P-value = 0.002 and 0.008 respectively whereas m.9377 was not statistically different. Most
marked is the difference in Danish nuclear ancestry for m.15043 A/G, with an inter-allelic
Fig 2. PCA of A. mtDNA (PC1 versus PC3) and B. gDNA (PC1 versus PC2), with the m.15043A (filled diamonds)
and m.15043G (filled circles) alleles. Only persons with “European” mtDNA haplogroup (H, HV, V, U, K, J & T) were
included. The PCA was performed using PCs defined by control samples.
https://doi.org/10.1371/journal.pone.0208828.g002
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difference ~ 20 percent points in Danish ancestry, and the A-allele has a prominent Central
South Asian ancestry not seen in the G-allele, Fig 3 and S2 Fig. PCA analyses of the gDNA,
Fig 2B, of the two alleles, reveal subtle differences in the genomic structure independent of the
nuclear ancestry between the two alleles. Thus, when comparing persons with either of two
alleles at the same mtDNA position, there is a risk for comparison between groups with widely
different ancestries, thus increased risk of confounding by population structure.
Association between schizophrenia and mtDNA SNPs
The association of each mtDNA SNP with SZ was assessed (Fig 4). In consequence of the
inter-allelic differences in mtDNA hg affiliations and nuclear ancestry demonstrated above,
several association analyses were performed. Five SNPs, m.1438A, m.3197C, m.3666A,
m.4769A, and m.9377G showed no association with SZ, both when all persons were included
and where selection was made to reduce effects of varying mtDNA and nuclear ancestry affilia-
tions. The m.10398G SNP was marginally significantly, while m.15043A was significantly asso-
ciated with reduced risk of SZ in All and All-Danish mtDNA hgs. The m.15218G was
associated significantly, or borderline significantly, with a reduced risk for SZ irrespective of
the grouping, Fig 4. The high level of diversity in the PCA analysis of m.15043A (and the
remaining SNPs—data not shown), Fig 2A, prompted us to examine whether a fixation of the
mtDNA hg, i.e. limiting the analysis to persons with a specific hg, in cases where it was reason-
ably frequent, would result in significant associations. The result, Table 2, was the contrary—
on a fixed mtDNA hg background, none of the SNPs exhibited a significant association
with SZ.
Discussion
Here we show the dependence of mtDNA SNPs with both mtDNA hgs and gDNA clusters due
to population structure and shared demographic history of mtDNA and gDNA, we have called
this relationship “bi-genomic dependence”. This has the consequence that an association
between a particular allele, in a specific SNP, and disease is not exclusively the result of the
presence of that particular allele; since each mtDNA allele is associated with the unique distri-
butions of both mtDNA hgs and gDNA clusters. Furthermore, bi-genomic dependence can be
accounted for by including mtDNA and gDNA principle components from PCAs in associa-
tion analyses—thus incorporating a bi-genomic measure of population stratification and
Fig 3. The percentage distribution of nuclear ancestries, per allele, among control individuals.
https://doi.org/10.1371/journal.pone.0208828.g003
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admixture into mtDNA association analyses. Currently, such a measure of bi-genomic depen-
dence is not incorporated into studies of mtDNA-disease-association which consider an asso-
ciation as evidence for a specific effect of an allele on the function of a protein or RNA coded
for by the mtDNA and, consequently, as a cause of pathophysiological changes.
Fig 4. Association between individual mtDNA SNPs and schizophrenia as a function of the selection of the
involved persons. (All hgs: All persons, EU hgs: persons with a “classical European” mtDNA hg; EU_hgs_DANES:
persons with both a European mtDNA hg and a Danish nuclear ancestry and ALL_hgs_DANES: persons with a
Danish nuclear ancestry).
https://doi.org/10.1371/journal.pone.0208828.g004
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The linkage disequilibrium between different alleles of a SNP and mtDNA hgs and sub-hgs
is not surprising as hgs are defined by series of evolutionarily conserved SNPs. The particular
distribution of subsets of mtDNA hgs, sub-hgs and individual SNPs that are associated with a
particular allele at a specific SNP will depend on the population history and the extent and
source of admixture. In most countries, and in particular in Europe, such history is very com-
plicated and incompletely clarified. m.10398G was found associated with SZ in Han Chinese,
however, when the cohort was broken down with respect to mtDNA hgs, the association disap-
peared [24]. This illustrates that a specific allele’s mtDNA hg distribution may induce spurious
association with SZ. Spurious associations between mtDNA SNPs and a particular phenotype,
when restricted to persons of a specific mtDNA hg [25], may however be due to population
stratification at the sub-hg level. In the iPSYCH cohort there was no association between SZ
and any of the European mtDNA hgs (Data not shown).s mtDNA replicates independently of
the cell cycle and without recombination, mtDNA hgs and SNPs should be independent of the
gDNA, but only if the population is infinitely large and in the absence of population substruc-
ture. This is often not the case, due to geographical population substructure, recent admixture,
socially and culturally defined restrictions in choice of spouse. A recent study showed that
most Danish grandparents to present-day high school students chose spouses within a short
distance of their birthplace [26]. This practice will, with time, lead to regionalization, and a
southwestern to northeastern gradient was found [26]. Furthermore, immigrants may seek a
partner from within their ethnic community. Such effects have been eliminated in some stud-
ies by restricting the participants in mtDNA association studies to persons with a three-gener-
ation presence in the population. However, it has not been documented that this is sufficient
to obviate association or linkage disequilibrium between mtDNA SNPs and specific gDNA
clusters. Extensive gDNA micro-scale heterogeneity has been documented in the UK [21] and
Western France [27] and admixture has been an important factor in the accretion of the pres-
ent-day genomic variation of Europe [22, 28]. The UK study [21] showed that this is not just a
result of recent demic changes; however, recent migrations may lead to widespread bi-geno-
mic dependence.
Schizophrenia is a complex syndromic disease [29] with geographically varying prevalence
[30] and characterized by a markedly elevated prevalence among first and second generation
immigrants [31, 32], particularly among persons with dark skin moving to Nordic latitudes
[33]. These epidemiological characteristics of SZ obviously increase the risk of spurious
Table 2. Association of SNPs with SZ in Danish nuclear ancestry and a specific mtDNA haplogroup.
mtDNA hg Allele Odds-ratio (95% cfi) p SZ (N) Controls (N)
H m.1438A 1.05 (0.84–1.29) 0.7 110 1,000
m.3666A 1.12 (0.13–4.71) 0.7 2 17
m.4769A 1.03 (0.83–1.28) 0.7 105 966
m.9377A 0.95 (0.38–3.07) 0.8 1,046 9,917
m.10398A 0.79 (0.18–7.14) 0.7 1,049 9,947
m.15218A 1.09 (0.47–3.09) 1 1,045 9,900
J m.3666A 0.74 (0.08–3.06) 1 2 22
K m.9377A 0.90 (0.38–2.58) 0.8 133 1,509
m.10398A 1.40 (0.90–2.12) 0.1 33 106
U m.3197C 1.08 (0.85–1.38) 0.6 189 1,572
m.3666A 2.59 (0.46–10.13) 0.2 3 10
m.15218A 0.81 (0.63–1.04) 0.1 211 1,939
T m.15043A 0.99 (0.59–1.58) 1 22 208
https://doi.org/10.1371/journal.pone.0208828.t002
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associations caused by subtle admixture and bi-genomic dependence. However, it does not per
se refute the mitochondrial pathogenic paradigm [34] where variation in mitochondrial func-
tion, believed to interfere with ATP production [35, 36], inflammation and signaling [37, 38]
as well as Ca2+-homeostasis [39], and apoptosis [38], is considered to be of paramount impor-
tance for development of disease. Several neuroanatomical post-mortem findings in SZ brains
indicate perturbed mitochondrial function [40], but such findings are difficult to distinguish
from changes caused by drug treatment.
The iPSYCH data are prospective and signs of immigration are apparent [20], but they also
showed that the variation in ancestry differed greatly between mtDNA hgs—even within tradi-
tional European hgs, i.e. mtDNA hg U, where ancient European sub-hgs occurred together
with U-sub-hgs of recent Near Eastern and Central Asian origin [20]. Thus, bi-genomic
dependence is likely to be a confounder and may lead both to false positive as well as false neg-
ative associations with disease. The method of correction for bi-genomic dependence in asso-
ciation studies will depend on the specific mtDNA SNP examined, the population structure
and history, as well as the size of the study population.
If population stratification involving gDNA is inherent when performing association stud-
ies with mtDNA SNPs, it should be expected that diseases with geographically varying preva-
lence would be likely to find associated with specific mtDNA SNPs. The largest mtDNA
association study to date [18] found mtDNA SNPs associated with ulcerative colitis, exhibiting
a European North-South and East-West gradient [41], and with multiple sclerosis exhibiting a
longitudinal prevalence gradient [42] and effect of immigration [43]. The same study found
that the prevalence of mtDNA SNPs associated with Parkinson’s disease was lower in African
and Asian people [44]. Furthermore, the incidence of primary biliary cirrhosis is very high in
North East England, 50% lower in the rest of England and Scandinavia, and 90% lower in the
Middle East and Asia [45].
A major problem with the interpretation of mtDNA SNP variants is the difficulties associ-
ated with performing a meaningful and reproducible assessment of mitochondrial function. In
vitro studies of mitochondrial function, e.g. enzymatic activity measurements of OXPHOS
components in cells, tissues [46] or cybrids [47] as well as allotopic expression [15], are difficult
to interpret as they also interfere with the inherent cellular control of mitochondrial function
[38]. Furthermore, it should be noted, that mtDNA hgs and sub-hgs are cladistics groups and
not functional units. Thus, in the Danish population, the U-hg is composed of a range of sub-
hgs, e.g. U5a, U5b, U6, U7, and U8, with widely differing nuclear ancestries, reflecting migra-
tions rather than selection [20]. It is thus meaningless to ascribe a specific functional effect to a
particular mtDNA hg—without having carefully examined both mtDNA and nuclear genetic
variation and corrected for stratifications in both.
Previous conflicting studies of disease associations with mtDNA have been suggested to be
the result of insufficient power [48], insufficient stratification respect to sex, age, geographical
background [49] or population admixture [50], or the use of small areas of recruitment risking
“occult” founder effects [51]. The fact that careful control, as here, of these factors and the bi-
genomic dependence, results in none of eight previously SZ associated mtDNA SNPs being
associated with SZ in the very large Danish iPSYCH cohort, suggests that previously reported
associations could indeed be spurious findings due to cryptic population stratification. Meta-
analyses pooling studies from different populations [15] does not necessarily solve this prob-
lem—it may aggravate it by introducing further sub-stratification of the total population ana-
lyzed. The extensive bi-genomic dependence demonstrated in the Danish population makes
this phenomenon the most parsimonious explanation of non-replicable associations with
mtDNA variants, not only associations with SZ, but obviously bi-genomic dependence can
interfere with associations between mtDNA and all types of diseases and traits.
Bi-genomic dependence obscures schizophrenia-association with mtDNA SNPs
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Materials and methods
Ethics statement
The iPSYCH cohort study (www.ipsych.au.dk) is register-based using data from Danish
national health registries. The study was approved by the Scientific Ethics Committees of the
Central Denmark Region (www.komite.rm.dk) (J.nr.: 1-10-72-287-12) and executed according
to guidelines from the Danish Data Protection Agency (www.datatilsynet.dk) (J.nr.: 2012-41-
0110). Passive, but not informed, consent was obtained, in accordance with Danish Law nr.
593 of June 14, 2011, para 10, on the scientific ethics administration of projects within health
research.
SZ patients and controls
As part of the iPSYCH recruitment protocol, 23,743 controls, born between May 1st 1981 and
Dec 31st 2005 were selected at random from the Danish Central Person Registry. Among per-
sons born within the same time span 2,538 persons assigned an ICD-10 F20 were identified in
the Danish National Patient Registry. All were singletons, were alive one year after their birth,
and had a mother registered in the Danish Central Person Registry. DNA was available from
DBS cards obtained from the Danish Neonatal Screening Biobank at Statens Serum Institut
[52] Demographics of patients and controls are given in S1 Table.
Genetic analysis and mtDNA SNPing
From each DBS card two 3.2-mm disks were excised from which DNA extracted using
Extract-N-Amp Blood PCR Kit (Sigma-Aldrich, St Louis, MO, USA)(extraction volume:
200 μL). The extracted DNA samples were whole genome amplified (WGA) in triplicate using
the REPLIg kit (Qiagen, Hilden, Germany), then pooled into a single aliquot. Finally, WGA
DNA concentrations were estimated using the Quant-IT Picogreen dsDNA kit (Invitrogen,
Carlsbad, CA, USA). The amplified samples were genotyped at the Broad Institute (MA, USA)
using the PsychChip (Illumina, CA, USA) typing 588,454 variants, developed by the Psychiat-
ric Genetic Consortia. We then isolated the 418 mitochondrial loci and reviewed the genotype
calls, before exporting into the PED/MAP format using GenomeStudio (Illumina, CA, USA).
Haplo-grouping of mtDNA was performed using the defining SNPs reported in www.
phylotree.org [53].
Nuclear ancestry
Nuclear ancestry estimation was done using ADMIXTURE 1.3.050 in the supervised approach.
Briefly, reference populations consisting of Human Genome Diversity Project (HGDP)
(http://www.hagsc.org/hgdp/), a Danish (716 individuals) and a Greenlandian (592 individu-
als) genotyping SNP data set were used. The final reference data set consisted of 103,268 auto-
somal SNPs and 2,248 individuals assigned to one of nine population groups: Africa, America,
Central South Asia, Denmark, East Asia, non-Danish Europe, Greenland, Middle East and
Oceania. The number of clusters, K was set to eight, based on principal component analysis
clustering (data not shown). The subpopulations were merged with the reference population
data set and analyzed using ADMIXTURE. For prediction of the ancestry of individuals within
the mtDNA hgs we created a random forest model [54] based on the reference data set, with
the clusters Q1-8 as predictors and population groups as outcome. Thus, the ancestry analysis
of the individual person was the result of a supervised prediction. Prediction was done using
R3 version 3.2.2, using the Caret package.
Bi-genomic dependence obscures schizophrenia-association with mtDNA SNPs
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Statistics
The statistical significance of differences in mtDNA SNP proportions between controls and SZ
patients was assessed using a permutation version of Fisher’s exact test. Samples with missing
sequence data were excluded. To assess differences in allele distribution within the predicted
ancestries we used Pearson’s Chi-squared test. Ancestries with allele counts below six were not
included. Calculations were performed using R (version 3.1.3). Principal component analysis
(PCA), was prepared using PLINK (v.1.90b3.31). For the PCA the reference population vari-
ants were extracted from the iPSYCH control sample, LD pruned (indep-pairwise 50 5 0.5)
and allowing only SNPs with 99% genotyping rate. Prior to PCA of mtDNA data, samples
were loaded into GenomeStudio (version 2011.a), a custom cluster was created using Gentrain
(version 2), following automatic clustering, all positions with heterozygotes were manually
curated. The data was exported relative to the forward strand using PLINK Input Report Plug-
in (version 2.1.3). Eigenvectors were calculated using PLINK (v1.90b3.31). PCA plots were cre-
ated using the package ggplot2 (version 1.0.1) in R (version 3.1.3).
Supporting information
S1 Table. Demographics and nuclear ancestry and mtDNA haplogroups of the cohort.
(DOCX)
S1 Fig. Distribution of mtDNA haplogroups of schizophrenic patients with specific SNPs.
(TIF)
S2 Fig. Distribution of nuclear ancestries of schizophrenic persons with specific SNPs.
(TIF)
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Jonas Bybjerg-Grauholm, Marie Bækvad-Hansen, Christine S. Hansen, Jørgen K. Kanters,
Jimmi Nielsen, Ole Mors, Alfonso B. Demur, Thomas D. Als, Merete Nordentoft, Anders
Børglum, Preben B. Mortensen, James Kennedy, Thomas M. Werge, David M. Hougaard.
References
1. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, et al. Mitochondrial DNA mutation
associated with Leber’s hereditary optic neuropathy. Science. 1988; 242(4884):1427–30. PMID:
3201231.
2. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mito-
chondrial myopathies. Nature. 1988; 331(6158):717–9. https://doi.org/10.1038/331717a0 PMID:
2830540.
3. Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, et al. Mutation
of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat
Genet. 1995; 11(2):144–9. https://doi.org/10.1038/ng1095-144 PMID: 7550341.
4. Koopman WJ, Willems PH, Smeitink JA. Monogenic mitochondrial disorders. N Engl J Med. 2012;
366(12):1132–41. https://doi.org/10.1056/NEJMra1012478 PMID: 22435372.
5. Calvo SE, Mootha VK. The mitochondrial proteome and human disease. Annu Rev Genomics Hum
Genet. 2010; 11:25–44. https://doi.org/10.1146/annurev-genom-082509-141720 PMID: 20690818.
6. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, et al. A mitochondrial protein compen-
dium elucidates complex I disease biology. Cell. 2008; 134(1):112–23. https://doi.org/10.1016/j.cell.
2008.06.016 PMID: 18614015.
7. Vafai SB, Mootha VK. Mitochondrial disorders as windows into an ancient organelle. Nature. 2012;
491(7424):374–83. https://doi.org/10.1038/nature11707 PMID: 23151580.
8. Chinnery PF, Hudson G. Mitochondrial genetics. Br Med Bull. 2013; 106:135–59. https://doi.org/10.
1093/bmb/ldt017 PMID: 23704099.
9. Chinnery PF, Taylor GA, Howell N, Andrews RM, Morris CM, Taylor RW, et al. Mitochondrial DNA hap-
logroups and susceptibility to AD and dementia with Lewy bodies. Neurology. 2000; 55(2):302–4.
PMID: 10908912.
10. Carrieri G, Bonafe M, De Luca M, Rose G, Varcasia O, Bruni A, et al. Mitochondrial DNA haplogroups
and APOE4 allele are non-independent variables in sporadic Alzheimer’s disease. Hum Genet. 2001;
108(3):194–8. PMID: 11354629.
11. van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, et al. Analysis of
European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett. 2004; 365(1):28–32.
https://doi.org/10.1016/j.neulet.2004.04.051 PMID: 15234467.
12. Coskun P, Wyrembak J, Schriner SE, Chen HW, Marciniack C, Laferla F, et al. A mitochondrial etiology
of Alzheimer and Parkinson disease. Biochim Biophys Acta. 2012; 1820(5):553–64. https://doi.org/10.
1016/j.bbagen.2011.08.008 PMID: 21871538.
13. Hudson G, Nalls M, Evans JR, Breen DP, Winder-Rhodes S, Morrison KE, et al. Two-stage association
study and meta-analysis of mitochondrial DNA variants in Parkinson disease. Neurology. 2013; 80(22):
2042–8. https://doi.org/10.1212/WNL.0b013e318294b434 PMID: 23645593.
14. Pyle A, Foltynie T, Tiangyou W, Lambert C, Keers SM, Allcock LM, et al. Mitochondrial DNA haplogroup
cluster UKJT reduces the risk of PD. Ann Neurol. 2005; 57(4):564–7. https://doi.org/10.1002/ana.20417
PMID: 15786469.
Bi-genomic dependence obscures schizophrenia-association with mtDNA SNPs
PLOS ONE | https://doi.org/10.1371/journal.pone.0208828 December 10, 2018 11 / 14
15. Marom S, Friger M, Mishmar D. MtDNA meta-analysis reveals both phenotype specificity and allele het-
erogeneity: a model for differential association. Sci Rep. 2017; 7:43449. https://doi.org/10.1038/
srep43449 PMID: 28230165.
16. Sequeira A, Martin MV, Rollins B, Moon EA, Bunney WE, Macciardi F, et al. Mitochondrial mutations
and polymorphisms in psychiatric disorders. Front Genet. 2012; 3:103. https://doi.org/10.3389/fgene.
2012.00103 PMID: 22723804.
17. Rollins B, Martin MV, Sequeira PA, Moon EA, Morgan LZ, Watson SJ, et al. Mitochondrial variants in
schizophrenia, bipolar disorder, and major depressive disorder. PLoS One. 2009; 4(3):e4913. https://
doi.org/10.1371/journal.pone.0004913 PMID: 19290059.
18. Hudson G, Gomez-Duran A, Wilson IJ, Chinnery PF. Recent mitochondrial DNA mutations increase the
risk of developing common late-onset human diseases. Plos Genet. 2014; 10(5):e1004369. https://doi.
org/10.1371/journal.pgen.1004369 PMID: 24852434.
19. Saxena R, de Bakker PI, Singer K, Mootha V, Burtt N, Hirschhorn JN, et al. Comprehensive association
testing of common mitochondrial DNA variation in metabolic disease. Am J Hum Genet. 2006; 79(1):
54–61. https://doi.org/10.1086/504926 PMID: 16773565.
20. Bybjerg-Grauholm J, Hagen, C. M. Goncalves, V. F., Bækvad-Hansen, M., Hansen, C.S., Hedley,P.L.,
Kanters, J.K., Nielsen, J., Theisen, M., Mors, O., Kennedy, J., Als, T.D., Demur, A.B., Nordentoft, M.,
Børglum,A.D., Mortensen, P.B., Werge, T.M., Hougaard, D.M., Christiansen, M. Complex spatio-
temporal distribution and genogeographical affinity of mitochondrial DNA haplogroups in 24,216 danes.
biorxiv/2017/148494. 2017.
21. Leslie S, Winney B, Hellenthal G, Davison D, Boumertit A, Day T, et al. The fine-scale genetic structure
of the British population. Nature. 2015; 519(7543):309–14. https://doi.org/10.1038/nature14230 PMID:
25788095.
22. Busby GB, Hellenthal G, Montinaro F, Tofanelli S, Bulayeva K, Rudan I, et al. The Role of Recent
Admixture in Forming the Contemporary West Eurasian Genomic Landscape. Curr Biol. 2015; 25(19):
2518–26. https://doi.org/10.1016/j.cub.2015.08.007 PMID: 26387712.
23. Zhang W, Tang J, Zhang AM, Peng MS, Xie HB, Tan L, et al. A matrilineal genetic legacy from the last
glacial maximum confers susceptibility to schizophrenia in Han Chinese. J Genet Genomics. 2014;
41(7):397–407. https://doi.org/10.1016/j.jgg.2014.05.004 PMID: 25064678.
24. Du C, El Harchi A, Zhang H, Hancox JC. Modification by KCNE1 variants of the hERG potassium chan-
nel response to premature stimulation and to pharmacological inhibition. Physiol Rep. 2013; 1(6):
e00175. https://doi.org/10.1002/phy2.175 PMID: 24400172.
25. Ji Y, Zhang AM, Jia X, Zhang YP, Xiao X, Li S, et al. Mitochondrial DNA haplogroups M7b1’2 and M8a
affect clinical expression of leber hereditary optic neuropathy in Chinese families with the m.11778G—
>a mutation. Am J Hum Genet. 2008; 83(6):760–8. https://doi.org/10.1016/j.ajhg.2008.11.002 PMID:
19026397.
26. Athanasiadis G, Cheng JY, Vilhjalmsson BJ, Jorgensen FG, Als TD, Le Hellard S, et al. Nationwide
Genomic Study in Denmark Reveals Remarkable Population Homogeneity. Genetics. 2016; 204(2):
711–22. https://doi.org/10.1534/genetics.116.189241 PMID: 27535931.
27. Karakachoff M, Duforet-Frebourg N, Simonet F, Le Scouarnec S, Pellen N, Lecointe S, et al. Fine-scale
human genetic structure in Western France. Eur J Hum Genet. 2015; 23(6):831–6. https://doi.org/10.
1038/ejhg.2014.175 PMID: 25182131.
28. Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, Auton A, et al. Genes mirror geography within
Europe. Nature. 2008; 456(7218):98–101. https://doi.org/10.1038/nature07331 PMID: 18758442.
29. Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016; 388(10039):86–97. https://doi.org/10.
1016/S0140-6736(15)01121-6 PMID: 26777917.
30. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence,
and mortality. Epidemiol Rev. 2008; 30:67–76. https://doi.org/10.1093/epirev/mxn001 PMID:
18480098.
31. Cantor-Graae E, Pedersen CB. Full spectrum of psychiatric disorders related to foreign migration: a
Danish population-based cohort study. JAMA Psychiatry. 2013; 70(4):427–35. https://doi.org/10.1001/
jamapsychiatry.2013.441 PMID: 23446644.
32. Cantor-Graae E, Selten JP. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry.
2005; 162(1):12–24. https://doi.org/10.1176/appi.ajp.162.1.12 PMID: 15625195.
33. Dealberto MJ. Ethnic origin and increased risk for schizophrenia in immigrants to countries of recent
and longstanding immigration. Acta Psychiatr Scand. 2010; 121(5):325–39. https://doi.org/10.1111/j.
1600-0447.2009.01535.x PMID: 20105146.
Bi-genomic dependence obscures schizophrenia-association with mtDNA SNPs
PLOS ONE | https://doi.org/10.1371/journal.pone.0208828 December 10, 2018 12 / 14
34. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a
dawn for evolutionary medicine. Annu Rev Genet. 2005; 39:359–407. https://doi.org/10.1146/annurev.
genet.39.110304.095751 PMID: 16285865.
35. Kenney MC, Chwa M, Atilano SR, Falatoonzadeh P, Ramirez C, Malik D, et al. Molecular and bioener-
getic differences between cells with African versus European inherited mitochondrial DNA haplogroups:
implications for population susceptibility to diseases. Biochim Biophys Acta. 2014; 1842(2):208–19.
https://doi.org/10.1016/j.bbadis.2013.10.016 PMID: 24200652.
36. Larsen S, Diez-Sanchez C, Rabol R, Ara I, Dela F, Helge JW. Increased intrinsic mitochondrial function
in humans with mitochondrial haplogroup H. Biochim Biophys Acta. 2014; 1837(2):226–31. https://doi.
org/10.1016/j.bbabio.2013.10.009 PMID: 24184346.
37. Atilano SR, Malik D, Chwa M, Caceres-Del-Carpio J, Nesburn AB, Boyer DS, et al. Mitochondrial DNA
variants can mediate methylation status of inflammation, angiogenesis and signaling genes. Hum Mol
Genet. 2015; 24(16):4491–503. https://doi.org/10.1093/hmg/ddv173 PMID: 25964427.
38. Kenney MC, Chwa M, Atilano SR, Falatoonzadeh P, Ramirez C, Malik D, et al. Inherited mitochondrial
DNA variants can affect complement, inflammation and apoptosis pathways: insights into mitochon-
drial-nuclear interactions. Hum Mol Genet. 2014; 23(13):3537–51. https://doi.org/10.1093/hmg/ddu065
PMID: 24584571.
39. Raffaello A, Mammucari C, Gherardi G, Rizzuto R. Calcium at the Center of Cell Signaling: Interplay
between Endoplasmic Reticulum, Mitochondria, and Lysosomes. Trends Biochem Sci. 2016; 41(12):
1035–49. https://doi.org/10.1016/j.tibs.2016.09.001 PMID: 27692849.
40. Verge B, Alonso Y, Valero J, Miralles C, Vilella E, Martorell L. Mitochondrial DNA (mtDNA) and schizo-
phrenia. Eur Psychiatry. 2011; 26(1):45–56. https://doi.org/10.1016/j.eurpsy.2010.08.008 PMID:
20980130.
41. Burisch J. Crohn’s disease and ulcerative colitis. Occurrence, course and prognosis during the first year
of disease in a European population-based inception cohort. Dan Med J. 2014; 61(1):B4778. PMID:
24393595.
42. Kurtzke JF. Geographic distribution of multiple sclerosis: An update with special reference to Europe
and the Mediterranean region. Acta Neurol Scand. 1980; 62(2):65–80. PMID: 6971038.
43. McLeod JG, Hammond SR, Kurtzke JF. Migration and multiple sclerosis in immigrants to Australia from
United Kingdom and Ireland: a reassessment. I. Risk of MS by age at immigration. J Neurol. 2011;
258(6):1140–9. https://doi.org/10.1007/s00415-010-5898-4 PMID: 21264474.
44. de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006; 5(6):525–35.
https://doi.org/10.1016/S1474-4422(06)70471-9 PMID: 16713924.
45. Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary
cirrhosis: a systematic review. J Hepatol. 2012; 56(5):1181–8. https://doi.org/10.1016/j.jhep.2011.10.
025 PMID: 22245904.
46. Aidt FH, Nielsen SM, Kanters J, Pesta D, Nielsen TT, Norremolle A, et al. Dysfunctional mitochondrial
respiration in the striatum of the Huntington’s disease transgenic R6/2 mouse model. PLoS Curr. 2013;
5. https://doi.org/10.1371/currents.hd.d8917b4862929772c5a2f2a34ef1c201 PMID: 23568011.
47. Arduino DM, Esteves AR, Swerdlow RH, Cardoso SM. A cybrid cell model for the assessment of the
link between mitochondrial deficits and sporadic Parkinson’s disease. Methods Mol Biol. 2015;
1265:415–24. https://doi.org/10.1007/978-1-4939-2288-8_31 PMID: 25634293.
48. Samuels DC, Carothers AD, Horton R, Chinnery PF. The power to detect disease associations with
mitochondrial DNA haplogroups. Am J Hum Genet. 2006; 78(4):713–20. https://doi.org/10.1086/
502682 PMID: 16532401.
49. Raule N, Sevini F, Santoro A, Altilia S, Franceschi C. Association studies on human mitochondrial DNA:
methodological aspects and results in the most common age-related diseases. Mitochondrion. 2007;
7(1–2):29–38. https://doi.org/10.1016/j.mito.2006.11.013 PMID: 17306632.
50. Biffi A, Anderson CD, Nalls MA, Rahman R, Sonni A, Cortellini L, et al. Principal-component analysis for
assessment of population stratification in mitochondrial medical genetics. Am J Hum Genet. 2010;
86(6):904–17. https://doi.org/10.1016/j.ajhg.2010.05.005 PMID: 20537299.
51. Achilli A, Rengo C, Magri C, Battaglia V, Olivieri A, Scozzari R, et al. The molecular dissection of
mtDNA haplogroup H confirms that the Franco-Cantabrian glacial refuge was a major source for the
European gene pool. Am J Hum Genet. 2004; 75(5):910–8. https://doi.org/10.1086/425590 PMID:
15382008.
52. Agerbo E, Mortensen PB, Wiuf C, Pedersen MS, McGrath J, Hollegaard MV, et al. Modelling the contri-
bution of family history and variation in single nucleotide polymorphisms to risk of schizophrenia: a Dan-
ish national birth cohort-based study. Schizophr Res. 2012; 134(2–3):246–52. https://doi.org/10.1016/j.
schres.2011.10.025 PMID: 22108675.
Bi-genomic dependence obscures schizophrenia-association with mtDNA SNPs
PLOS ONE | https://doi.org/10.1371/journal.pone.0208828 December 10, 2018 13 / 14
53. van Oven M, Kayser M. Updated comprehensive phylogenetic tree of global human mitochondrial
DNA variation. Hum Mutat. 2009; 30(2):E386–94. https://doi.org/10.1002/humu.20921 PMID:
18853457.
54. Breiman L. Random forests. Machine Learning. 2001; 45(1):5–32. https://doi.org/10.1023/
A:1010933404324
Bi-genomic dependence obscures schizophrenia-association with mtDNA SNPs
PLOS ONE | https://doi.org/10.1371/journal.pone.0208828 December 10, 2018 14 / 14
